COVID-19–Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report

This publication has 23 references indexed in Scilit:

• Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients
  Journal of Stroke and Cerebrovascular Diseases, 2019
• Validation of the Stanford Proxy Test for Delirium (S-PTD) among critical and noncritical patients
  Journal of Psychosomatic Research, 2018
• Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article
  Inflammopharmacology, 2018
• Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure
  International Journal of Geriatric Psychiatry, 2017
• Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
  Esophagus, 2017
• Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review
  Psychosomatics, 2015
• Comparison of delirium assessment tools in a mixed intensive care unit*
  Critical Care Medicine, 2009
• A prototypical Sigma-1 receptor antagonist protects against brain ischemia
  Brain Research, 2007
• Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
  JAMA, 2004
• Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)
  Critical Care Medicine, 2001